Holen Sie sich die Stockscreener-App
102.30
0.55%
-0.57
Handel nachbörslich:
102.60
0.30
+0.29%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Abbott Laboratories Aktie (ABT) Neueste Nachrichten
Evercore ISI Lowers Price Target for Abbott Laboratories (ABT) t - GuruFocus
Medical Foods Market Is Going to Boom |• Abbott • Danone - openpr.com
Rathbones Group PLC Increases Position in Abbott Laboratories $ABT - marketbeat.com
Abbott’s Lisa Earnhardt to deliver DeviceTalks Minnesota keynote - MassDevice
Abbott Laboratories $ABT Holdings Reduced by Cidel Asset Management Inc. - marketbeat.com
Abbott Laboratories $ABT Shares Acquired by BXM Wealth LLC - marketbeat.com
Abbott India Ltd stock: What you need to know for smart investing now - AD HOC NEWS
The Best Dividend ETF to Buy in April 2026 If You Want Passive Income - The Motley Fool
Abbott Laboratories Embarks on a Transformative $23 Billion Acquisition - AD HOC NEWS
ABT SEC FilingsAbbott Labs 10-K, 10-Q, 8-K Forms - Stock Titan
Abbott launches nationwide campaign on National Vitamin C Day to highlight role of micronutrient in wellness - MediaNews4U
A Dividend Dynasty: Abbott Laboratories' Enduring Payout Streak - AD HOC NEWS
Exact Sciences Corp. stock: Acquired by Abbott – What it means for you now - AD HOC NEWS
Erste Group Keeps Their Hold Rating on Abbott Laboratories (ABT) - The Globe and Mail
Abbott Stock Sits 26% Off Its Peak While Analysts Back a $132 Mean Price Target - TIKR.com
Abbott Laboratories (ABT) latest stock news and headlines - Yahoo Finance Singapore
Analysts’ Top Healthcare Picks: Abbott Laboratories (ABT), Cogent Biosciences (COGT) - The Globe and Mail
Aberdeen Group plc Increases Holdings in Abbott Laboratories $ABT - marketbeat.com
Abbott India Ltd Stock: A Stable Player in India's Booming Healthcare Sector for Long-Term Investors - AD HOC NEWS
What Abbott Laboratories (ABT)'s Oncology Test Integration Into OncoEMR Means For Shareholders - simplywall.st
Abbott Laboratories (ABT) director receives 382 stock equivalent units as fees - Stock Titan
Director at Abbott (NYSE: ABT) receives stock equivalent unit award - Stock Titan
Abbott (ABT) director Gonzalez receives 321 stock equivalent units as fees - Stock Titan
Abbott (ABT) director Robert Alpern awarded 76 stock equivalent units as fees - Stock Titan
Abbott Laboratories (ABT) director Nita Ahuja granted 102 stock equivalent units - Stock Titan
Sinocare Can't Scrap Abbott's Glucose Monitor Ban At UPC - Law360
Compagnie Lombard Odier SCmA Makes New Investment in Abbott Laboratories $ABT - MarketBeat
What's Driving Abbott Labs Today - Yahoo
Abbott India Ltd Stock: Steady Growth in India's Pharmaceutical Sector Amid Evolving Healthcare Dema - AD HOC NEWS
Bank Pictet & Cie Europe AG Decreases Position in Abbott Laboratories $ABT - MarketBeat
Banque Pictet & Cie SA Sells 83,130 Shares of Abbott Laboratories $ABT - MarketBeat
Drug Delivery Device Market Is Booming Worldwide 2026-2033 | - openPR.com
Abbott Laboratories Expands into Wearable Technology Through Whoop Investment - AD HOC NEWS
Abbott’s Whoop Investment Puts Digital Health Wearables On Shareholders’ Radar - Yahoo Finance
Assessing Abbott Laboratories (ABT) Valuation After New Flatiron Health Oncology Integration - simplywall.st
Abbott Laboratories completed the acquisition of North Island Assets of Synlait Milk from Synlait Milk Limited. - MarketScreener
Abbott joins $575M funding round for wearable maker Whoop - MassDevice
Abbott: A Brighter Investment Case Heading Into Q1 Earnings (Rating Upgrade) (NYSE:ABT) - Seeking Alpha
Best Healthcare Stocks to Buy Right Now for Long-Term Growth - The Motley Fool
Reasons to Retain Abbott Stock in Your Portfolio Now - TradingView
Here is What to Know Beyond Why Abbott Laboratories (ABT) is a Trending Stock - Yahoo Finance
20,751 Shares in Abbott Laboratories $ABT Bought by Shrier Wealth Management LLC - MarketBeat
Analysts Offer Insights on Healthcare Companies: Abbott Laboratories (ABT), Edwards Lifesciences (EW) and Palisade Bio (PALI) - The Globe and Mail
Abbott Laboratories Pakistan : Change in Date and Time of the 77th Annual General Meeting - MarketScreener
List of 29 Acquisitions by Abbott (Apr 2026) - Tracxn
Whoop raises $575M—Abbott, LeBron James, Cristiano Ronaldo among the investors - Cardiovascular Business
Abbott Oncology Integration Into OncoEMR Tests Long Term Growth Story - simplywall.st
Whoop raises $575M, adds Abbott as strategic investor - medtechdive.com
Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Abbott Laboratories (ABT) - The Globe and Mail
Abbott integrates Precision Oncology portfolio into Flatiron’s OncoEMR - Yahoo Finance
BTIG Research Lowers Abbott Laboratories (NYSE:ABT) Price Target to $131.00 - marketbeat.com
BTIG Research Adjusts Abbott Laboratories PT to $131 From $140, Maintains Buy Rating - marketscreener.com
Whoop Raises $575M at $10.1B Valuation, Abbott Joins as Investor - Athletech News
Abbott Laboratories $ABT Position Trimmed by J. Safra Sarasin Holding AG - marketbeat.com
Abbott Laboratories $ABT Shares Bought by Mn Services Vermogensbeheer B.V. - marketbeat.com
Abbott (ABT) Enhances Cancer Care with OncoEMR Test Integration - GuruFocus
Abbott (ABT) Dips More Than Broader Market: What You Should Know - Yahoo Finance Australia
Dairy industry consolidation | Lactalis, Abbott Complete Major NZ Dairy Deals - en.edairynews.com
SCHD ETF Rebalance Adds Abbott, UnitedHealth as Dividend Fund Inflows Hit 4-Year High - TechStock²
Abbott Laboratories stock underperforms Monday when compared to competitors - MarketWatch
Abbott Laboratories (NYSE:ABT) Reaches New 1-Year LowShould You Sell? - marketbeat.com
Will Integrating Precision Oncology Tests into OncoEMR Change Abbott Laboratories' (ABT) Narrative? - Yahoo Finance
Abbott, Flatiron Health Integrate Precision Oncology Tests Into Oncology EMR Platform - Clinical Lab Products
Abbott Laboratories stock hits 52-week low at 102.39 USD - Investing.com
Abbott Laboratories stock hits 52-week low at 102.39 USD By Investing.com - Investing.com Australia
Abbott integrates cancer tests into Flatiron’s EMR platform By Investing.com - in.investing.com
Abbott integrates cancer tests into Flatiron’s EMR platform - Investing.com
Abbott expands access to Precision Oncology portfolio through integration with Flatiron's OncoEMR® platform - MarketScreener
4,700 cancer providers can now order Abbott tests in their records system - Stock Titan
0.23%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):